CLINICAL_TRIALS
trial_result
· 2023-04-21
Clinical Trial Update: The Effect of RNS60 on ALS Biomarkers [Phase 2]
Summary
Phase 2 trial assessing the effect of RNS60 on ALS biomarkers has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2023-04-21